Oral cancer

You have access
Correlation Analysis Between IFIT2 and HLA Class II in Oral Cancer
KUO-CHU LAI, CHI-WEI CHEN, PETER MU-HSIN CHANG, YI-CHUN LIAO, CHUANG-WEI WANG, CHIA-HSUN HSIEH and TSUNG-TENG HUANG

Anticancer Research May 2025, 45 (5) 1897-1914; DOI: https://doi.org/10.21873/anticanres.17568
Open Access
PIK3CA Hotspot Mutations in Saliva as a Diagnostic Marker in Oral Squamous Cell Carcinoma Patients
KONSTANTIN KRÜGER, AUDREY GRUST, DAVID MUALLAH, ADRIAN PATENGE, HARRIET WIKMAN, MARIA MEDINA MESA, EIKE SÖREN KNUST, ALEXANDER SARTORI, RALF SMEETS, LAN KLUWE, REINHARD E. FRIEDRICH and SIMON BURG

Anticancer Research June 2024, 44 (6) 2369-2376; DOI: https://doi.org/10.21873/anticanres.17044
Open Access
Ex Vivo Evaluation of Antiangiogenic Drugs in Oral Cancer: Potential Implications for Targeting Vasculogenic Mimicry
ROOSA HUJANEN, TUULA SALO, KARI K. EKLUND and ABDELHAKIM SALEM

Anticancer Research June 2024, 44 (6) 2377-2392; DOI: https://doi.org/10.21873/anticanres.17045
Open Access
Multimodal Prediction of Cervical Lymph Node Metastasis and Recurrence in Oral Squamous Cell Carcinoma
HIDEKA KANEMOTO, KYOICHI OBATA, KOKI UMEMORI, KAZUAKI HASEGAWA, SAWAKO ONO, KISHO ONO, HIROKAZU YUTORI and SOICHIRO IBARAGI

Anticancer Research November 2023, 43 (11) 4993-5001; DOI: https://doi.org/10.21873/anticanres.16698
You have access
Fucoidan Enhances Cisplatin-induced Effects on SCC-25 Human Oral Cancer Cells by Inhibiting the PI3K/AKT Pathway
CHING-HUEY YANG, YUN-CHING CHANG, CHUNG-CHI HSU, CHENG-HAN LIN, I-JU CHEN, YEN-TING WU and YU-YAN LAN

Anticancer Research September 2023, 43 (9) 4015-4022; DOI: https://doi.org/10.21873/anticanres.16589
Open Access
EZH2 Expression Correlates With T-Cell Infiltration in Oral Leukoplakia and Predicts Cancer Transformation
DIVYA GANESH, AMAL DAFAR, JULIA NIKLASSON, INGRID SANDBERG, PAULO BRAZ-SILVA, DIPAK SAPKOTA, JENNY ÖHMAN, DANIEL GIGLIO and BENGT HASSÉUS

Anticancer Research April 2023, 43 (4) 1533-1542; DOI: https://doi.org/10.21873/anticanres.16302
You have access
Real-world Data Study of the Efficacy and Toxicity of Nivolumab vs. Cetuximab and Predictors of Response to Nivolumab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck in a European Population
LOLA MACIA-RIVAS, CLARA LUZ FERNANDEZ-LAGUNA, CRISTINA ALVAREZ-ASTEINZA, IVAN MARAY, MONICA CARBAJALES-ALVAREZ and ANA LOZANO-BLAZQUEZ

Anticancer Research April 2023, 43 (4) 1681-1688; DOI: https://doi.org/10.21873/anticanres.16320
You have access
Immunohistochemical Analysis of Common Cancer Antigens in Head and Neck Squamous Cell Carcinoma
YOHEI MORISHITA, KAZUMASA TAKENOUCHI, SHINGO SAKASHITA, KAZUTO MATSUURA, RYUICHI HAYASHI and TETSUYA NAKATSURA

Anticancer Research December 2022, 42 (12) 5751-5761; DOI: https://doi.org/10.21873/anticanres.16082
Open Access
The Contribution of Flap Endonuclease 1 Genotypes to Oral Cancer Risk
SHIH-HAN PAN, WEI-CHING CHIEN, JIE-LONG HE, LIANG-CHUN SHIH, CHE-LUN HSU, TE-CHUN HSIA, YUN-CHI WANG, HAO-YUAN TSAO, CHIA-WEN TSAI, DA-TIAN BAU and WEN-SHIN CHANG

Anticancer Research September 2022, 42 (9) 4329-4335; DOI: https://doi.org/10.21873/anticanres.15933
You have access
Handgrip Strength Predicts Poorly the Surgical Outcome or Length of Hospitalization in Patients With Surgically Operated Oral Cancer
JUHO SUOJANEN, SATU KAINULAINEN, LAURA TARVAINEN, JYRKI TORNWALL and TOMMY WILKMAN

Anticancer Research May 2022, 42 (5) 2771-2774; DOI: https://doi.org/10.21873/anticanres.15756

Main menu

User menu

Search

Oral cancer

Pages